Laboratory of Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands.
Curr Opin Chem Biol. 2010 Apr;14(2):138-44. doi: 10.1016/j.cbpa.2009.11.017. Epub 2009 Dec 16.
Baeyer-Villiger monooxygenases For many enzyme classes, a wealth of information on, for example, structure and mechanism has been generated in the last few decades. While the first Baeyer-Villiger monooxygenases (BVMOs) were already isolated more than 30 years ago, detailed data on these enzymes were lacking until recently. Over the last years several major scientific breakthroughs, including the elucidation of BVMO crystal structures and the identification of numerous novel BVMOs, have boosted the research on BVMOs. This has led to intensified biocatalytic explorations of novel BVMOs and structure-inspired enzyme redesign. This review provides an overview on the recently gained knowledge on BVMOs and sketches the outlook for future industrial applications of these unique oxidative biocatalysts.
过氧化物酶体增殖物激活受体γ共激活因子 1α 激动剂在非酒精性脂肪性肝病治疗中的应用进展
过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC-1α)是一种转录共激活因子,在调控能量代谢中发挥重要作用。非酒精性脂肪性肝病(NAFLD)是一种与胰岛素抵抗和遗传易感性密切相关的代谢应激性肝脏疾病,其特征为肝脏脂肪变性、脂肪性肝炎、肝纤维化和肝硬化。越来越多的证据表明,PGC-1α 激动剂在改善代谢和肝脏疾病方面具有治疗潜力。本文就 PGC-1α 激动剂在 NAFLD 治疗中的应用进展作一综述。